ArticleFrontiers in oncology2022

Commentary: The Tumor Markers and Blood Inflammation Markers Are More Likely to Be the Indicators for Differentiating Benign and Malignant Pancreatic Mucinous Cystic Neoplasms.

Jiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.